about
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemiaVorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanismsGenome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia.Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia.miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemiaSmall-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry.Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patientsCurcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia.The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML)Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaEpigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemiaDNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil.The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cellsEpigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene scoreThe Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia.Exploiting cellular pathways to develop new treatment strategies for AML.Gene expression profiling in MDS and AML: potential and future avenues.Knockdown of RLIP76 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to daunorubicin in U937 leukemia cells.Significance of Inactivated Genes in Leukemia: Pathogenesis and PrognosisChallenges ahead for mass spectrometry and proteomics applications in epigenetics.MGMT promoter methylation as a potential prognostic marker for acute leukemia.Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia.AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia.Identification of DNA methylation prognostic signature of acute myelocytic leukemia.Deacetylase activity-independent transcriptional activation by HDAC2 during TPA-induced HL-60 cell differentiationNucleoporin Gene Fusions and Hematopoietic Malignancies
P2860
Q27851713-29BB6967-68D7-4F94-B63A-5E0987824509Q28484904-196F4A93-804A-4211-B4A7-C94A365FCA5DQ30449092-789F9487-A72F-48D7-BAD2-1434DA8FF204Q33772607-97E18DBF-1E8E-4D08-9026-1EE589DB5BE2Q33982491-E2F83CEC-BC74-4BEA-B5B9-BC752F9211E2Q34123085-3347E1AC-C1FB-4CE1-9D8C-19106494CDCAQ34426853-48D3DCA2-CECB-47D6-9C84-E7486754A63BQ34606426-67CED42F-3953-49F8-91D7-FDB5B5020120Q34643306-C70B03D1-A855-49F3-AEE1-CBA0E01FC063Q34840020-0410FE12-8780-478C-B837-BCD97B367D5BQ35533613-7B479E9C-6CFB-4135-A4FD-4B81FDD3D6FAQ35806891-947A5010-A9CB-43B7-9377-FB93F74C71EEQ35816855-19DA1E5D-810F-4130-B188-D884B7F42335Q36413395-B231DAB6-028C-42E2-81DB-80FA2B9E53F7Q36972667-BE4CFFDD-6368-42B5-A886-B951F73C51B0Q37570427-926E557B-C5CC-4591-AE3C-573C77BBB7D9Q37629537-52276893-4621-491C-8A1D-A2EE5A976D80Q37670417-74E4A722-36EB-46DE-9AAB-9BA891A7F83EQ37858877-97431290-7898-448F-996E-AA0695DBDA14Q38993967-423FE8B3-D117-4DD5-822C-EAB8BB49429AQ39350173-286B404E-8A31-4B13-B015-D335ABAF50C7Q39905417-52B87DF7-758F-494A-92CC-B4EA86C4B243Q47138733-B12742DA-78FD-4038-89BC-E635772F6BECQ47831063-56311DB2-4DCA-41A4-879C-D73AF707BB81Q51748142-996A7EEE-A821-443C-AB30-DA6EE9C5ACB0Q55261830-E26FCFFB-5765-4699-8B47-498262BFEB71Q55439053-F6AB041E-EA2C-48BF-BB5D-200459073DE9Q58708831-884037B3-E625-4E7A-8C97-378505F8488EQ59072645-01E110F8-A99B-4B72-8DB4-5AEC31198036
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetics in acute myeloid leukemia.
@en
Epigenetics in acute myeloid leukemia.
@nl
type
label
Epigenetics in acute myeloid leukemia.
@en
Epigenetics in acute myeloid leukemia.
@nl
prefLabel
Epigenetics in acute myeloid leukemia.
@en
Epigenetics in acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Epigenetics in acute myeloid leukemia.
@en
P2093
Christoph Plass
Christopher Oakes
William Blum
P2860
P304
P356
10.1053/J.SEMINONCOL.2008.04.008
P577
2008-08-01T00:00:00Z